Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online January 15, 2025.
Article Versions
- You are currently viewing a Latest version of this article (January 15, 2025 - 04:00).
- latest version (March 15, 2025 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2025 The Journal of Rheumatology
Author Information
- Paul Emery,
- Roy Fleischmann,
- Robert Wong,
- Karissa Lozenski,
- Yoshiya Tanaka,
- Vivian P. Bykerk,
- Clifton O. Bingham 3rd,
- Thomas W.J. Huizinga,
- Gustavo Citera,
- Vidya Perera,
- Bindu Murthy,
- Kelly Fellows Maxwell,
- Julie Passarell,
- William D Hedrich and
- Daphne Williams
- Professor Paul Emery, MD, FMedSci, Leeds NIHR Biomedical Research Centre, & Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
- Professor Roy Fleischmann, MD, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Dr Robert Wong, MD, Bristol Myers Squibb, Princeton, NJ, USA (at the time of analysis).
- Dr Karissa Lozenski, PhD, Bristol Myers Squibb, Princeton, NJ, USA.
- Dr Yoshiya Tanaka, MD, PhD, University of Occupational and Environmental Health – Japan, Kitakyushu, Japan.
- Dr Vivian Bykerk, BSc, MD, FRCPC, Hospital for Special Surgery, New York, NY, USA.
- Dr Clifton O Bingham, 3rd, MD, Johns Hopkins University, Baltimore, MD, USA.
- Dr Thomas WJ Huizinga, MD, PhD, Leiden University Medical Center, Leiden, Netherlands.
- Dr Gustavo Citera, MD, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina.
- Dr Vidya Perera, PhD, Bristol Myers Squibb, Princeton, NJ, USA.
- Dr Bindu Murthy, PharmD, Bristol Myers Squibb, Princeton, NJ, USA.
- Dr Kelly Fellows Maxwell, PhD, Cognigen Corporation, a Simulations Plus company, Buffalo, NY, USA.
- Mrs Julie Passarell, MA, Cognigen Division, a Simulations Plus company, Buffalo, NY, USA.
- Dr William D Hedrich, PhD, MS, Bristol Myers Squibb, Princeton, NJ, USA (at the time of analysis).
- Dr Daphne Williams, PharmD, Bristol Myers Squibb, Princeton, NJ, USA.
- CONFLICTS OF INTEREST: PE: consultant: AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galapagos, Gilead, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Samsung; grant/research support: AbbVie, Bristol Myers Squibb, Eli Lilly, Novartis, Pfizer, Roche, Samsung. RF: consultant: Amgen, AbbVie, Arthrosi, Bristol Myers Squibb, Eli Lily, Galapagos, Galvani, Gilead, GlaxoSmithKline, Novartis, Pfizer, Vyne; grant/research support: Amgen, AbbVie, Arthrosi, AstraZeneca, Biosplice, Bristol Myers Squibb, Eli Lilly, Gilead, GlaxoSmithKline, Horizon, Novartis, Pfizer, Regeneron, UCB. RW: shareholder: Bristol Myers Squibb; employee: Bristol Myers Squibb (at the time of analysis). KL, VP, BM: shareholders and employees: Bristol Myers Squibb. YT: speakers bureau: AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, GlaxoSmithKline, Mitsubishi-Tanabe, Pfizer; grant/research support: AbbVie, Asahi-Kasei, Boehringer-Ingelheim, Chugai, Daiichi-Sankyo, Eisai, Takeda. VB: consultant: AbbVie, Bristol Myers Squibb, Pfizer; grant/research support: Bristol Myers Squibb (to institution). COB: consultant: AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, Sanofi; grant/research support: Bristol Myers Squibb. TWJH: speakers bureau, consultant, grant/research support: Ablynx, Abbott, Biotest AG, Bristol Myers Squibb, Crescendo Bioscience, Eli Lilly, Epirus, Galapagos, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, UCB. GC: speakers bureau: AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, Sandoz; consultant: AbbVie, Amgen, Bristol Myers Squibb, Pfizer; grant/research support: Pfizer. KFM, JP: consultant: Bristol Myers Squibb; employee: Cognigen Division, a Simulations Plus company. WDH: none declared. DW: consultant: Black Diamond Network, Joule, Syneos; employee: Bristol Myers Squibb.
- Correspondence: Professor Paul Emery, MD, FMedSci, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds NIHR Biomedical Research Centre, Leeds, UK. Email: P.Emery{at}leeds.ac.uk
